Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01417936
What this trial is testing

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Symphogen A/S 26
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Early research (Phase 1)Looking for participantsNCT05877300
What this trial is testing

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Who this might be right for
Esophageal Diseases
Harvard Apparatus Regenerative Technology, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Early research (Phase 1)Temporarily pausedNCT05018871
What this trial is testing

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP

Who this might be right for
Cerebral Palsy
The Foundation for Orthopaedics and Regenerative Medicine 15
Not applicableLooking for participantsNCT06843707
What this trial is testing

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Who this might be right for
Lung CancerLungLung Cancer (NSCLC)+1 more
The First Affiliated Hospital of Guangzhou Medical University 2,500
Testing effectiveness (Phase 2)Study completedNCT00200707
What this trial is testing

BONAMI (BOne Marrow in Acute Myocardial Infarction)

Who this might be right for
Acute and Severe Myocardial Infarction
Nantes University Hospital 101
Testing effectiveness (Phase 2)Study completedNCT00192036
What this trial is testing

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 49
Not applicableStudy completedNCT05253144
What this trial is testing

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

Who this might be right for
Merkel Cell Carcinoma
University of Birmingham 64
Testing effectiveness (Phase 2)Study completedNCT00000771
What this trial is testing

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 68
Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Testing effectiveness (Phase 2)Study completedNCT03346967
What this trial is testing

Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency

Who this might be right for
Hormone Deficiency
Vinmec Research Institute of Stem Cell and Gene Technology 30
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Early research (Phase 1)Study completedNCT00095771
What this trial is testing

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Early research (Phase 1)Ended earlyNCT00100971
What this trial is testing

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Boston Medical Center 9
Early research (Phase 1)Ended earlyNCT01744171
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT02792036
What this trial is testing

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 8
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Next Page